Impact of TNF inhibitors on rheumatoid arthritis
スポンサーリンク
概要
- 論文の詳細を見る
- 2006-05-25
著者
-
TAKEUCHI Tsutomu
Division of Particle and Astrophysical Sciences, Nagoya University
-
Kameda Hideto
Division of Rheumatology, Department of Internal Medicine, School of Medicine, Keio University, Japa
-
Kameda Hideto
Department Of Rheumatology And Clinical Immunology Saitama Medical Center Saitama Medical University
-
Takeuchi Tsutomu
Department Of Rheumatology And Clinical Immunology Saitama Medical Center Saitama Medical University
-
AMANO Koichi
Division of Rheumatology and Clinical Immunology, Saitama Medical Center, Saitama Medical University
-
Amano Koichi
Department Of Rheumatology And Clinical Immunology Saitama Medical Center Saitama Medical University
-
Amano Koichi
Division Of Rheumatology And Clinical Immunology Saitama Medical Center Saitama Medical University
-
Kameda Hideto
Division Of Rheumatology And Clinical Immunology Department Of Internal Medicine Faculty Of Medicine
-
Kameda Hideto
Division Of Rheumatology Saitama Medical Center Saitama Medical School
-
Amano Kouichi
Division Of Rheumatology Saitama Medical Center Saitama Medical School
-
Kameda Hideto
Department Of Rheumatology/clinical Immunology Saitama Medical Center
-
Amano Koichi
Division Of Rheumatology And Clinical Immunology Department Of Internal Medicine Saitama Medical Cen
-
Takeuchi Tsutomu
Division Of Particle And Astrophysical Sciences School Of Science Nagoya University
関連論文
- Exploring Galaxy Evolution from Infrared Number Counts and Cosmic Infrared Background
- Clinical and Radiological Features of Acute-Onset Diffuse Interstitial Lung Diseases in Patients with Rheumatoid Arthritis Receiving Treatment with Biological Agents: Importance of Pneumocystis Pneumonia in Japan Revealed by a Multicenter Study
- Severe degenerative change of multiple organs mediated by chronic active Epstein-Barr virus infection with infected T-cell expansion
- Impact of trough serum level on radiographic and clinical response to infliximab plus methotrexate in patients with rheumatoid arthritis : results from the RISING study
- Japan College of Rheumatology 2009 guidelines for the use of tocilizumab, a humanized anti-interleukin-6 receptor monoclonal antibody, in rheumatoid arthritis
- Aberrant expression of BAFF in T cells of systemic lupus erythematosus, which is recapitulated by a human T cell line, Loucy
- Retrospective clinical study on the notable efficacy and related factors of infliximab therapy in a rheumatoid arthritis management group in Japan : one-year outcome of joint destruction (RECONFIRM-2J)
- Retrospective clinical study on the notable efficacy and related factors of infliximab therapy in a rheumatoid arthritis management group in Japan : one-year clinical outcomes (RECONFIRM-2)
- Retrospective clinical study on the notable efficacy and related factors of infliximab therapy in a rheumatoid arthritis management group in Japan (RECONFIRM)
- Differences between the Health Assessment Questionnaire Disability Index (HAQ-DI) and the modified HAQ (mHAQ) score before and after infliximab treatment in patients with rheumatoid arthritis